JRSBRT 7.4, p. 271-277

Stereotactic body radiotherapy (SBRT) for T2N0 (>3 cm) non-small cell lung cancer: Outcomes and failure patterns
Stephen J. Shamp, Saad Sheikh, Tangel Chang, Nicholas Damico, Phillip Linden, Afshin Dowlati, Mitchell Machtay and Tithi Biswas

Purpose/objectives: Outcomes of T2N0 lung cancer patients treated with stereotactic radiotherapy are not well known.

Methods and materials: We conducted a single institution retrospective review of patients with T2N0 NSCLC who were treated with SBRT. The local, regional, distant control rates were calculated from available clinical data. Survival outcomes were determined using the Kaplan Meier method.

Results: Fifty-six patients met our selection criteria. The two-year local control rate was 84.2%. The two and 5-year disease-free survival (DFS) and OS were 31.9% and 15.3% and 39.9% and 12.1%, respectively. Centroid BED10 > 150Gy was associated with improved DFS, (p = 0.014), and OS on univariable analysis (p=0.0132).

Conclusions: SBRT provides good local control for T2N0 NSCLC, but systemic failure remains problematic.

Keywords: Radiosurgery, carcinoma, non-small-cell lung cancer, treatment outcomes, retrospective studies

After payment has been processed for your order of a digital copy (PDF) of this article, you will see a download link on your completed order page and also receive an email containing a download link. The links, which will enable you to download one copy of the article, will expire after 24 hours.